Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)

NCT: NCT05197530 · RECRUITING

NCT IDNCT05197530
StatusRECRUITING
Start Date2021-12-30
Completion2026-06

Brief Summary

Lymphatic transport was previously examined by these investigators using Near InfraRed Indocyanine Green fluorescence imaging (NIR-ICG) of the upper extremities. They established reliable and reproducible methodologies in RA patients. The purpose of this phase 2 pilot is to study RA disease progression and effectiveness as well as the mechanism of action of clinical interventions using established NIR-ICG methodologies in previous studies.

Frequently Asked Questions

What is Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)?

Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA) is a clinical trial registered under NCT05197530. Current status: RECRUITING.

What is the status of NCT05197530?

The current status of NCT05197530 (Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)) is: RECRUITING.

When did Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA) start?

Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA) started on 2021-12-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.